Status:
COMPLETED
Non-invasive Neurally Adjusted Ventilator Assist or Continuous Positive Airway Pressure in Preterm Infants
Lead Sponsor:
St. Olavs Hospital
Collaborating Sponsors:
Norwegian University of Science and Technology
Conditions:
Premature Birth
Respiratory Distress Syndrome, Newborn
Eligibility:
All Genders
24-96 years
Phase:
NA
Brief Summary
Strategies to prevent lung injury, facilitate lung development, and to support the preterm infant's capacity to breathe are decisive. Continuous positive airway pressure (CPAP) is the gold standard in...
Detailed Description
This is a randomized cross-over study with AB/BA sequences. The infants will receive both interventions in 4 hours intervals, a 30 minutes period to change the breathing support and a 30 minutes wash ...
Eligibility Criteria
Inclusion
- spontaneously breathing preterm infants 24 to 96 hours old
- gestational age (GA) between week 28+0 and 31+6
- preterm infants with GA \< 28+0 with a postmenstrual age (PMA) \> 28 weeks
- at least 72 hours old treated with CPAP or NIV NAVA
Exclusion
- preterm infants with severe congenital malformation
- need for vasopressors
- preterm children in need of a specific respiratory support system due to medical reasons
Key Trial Info
Start Date :
April 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04333563
Start Date
April 14 2020
End Date
April 30 2022
Last Update
July 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pediatrics St Olavs Hospital
Trondheim, Norway